Introductions: Tuberculosis is the most common comorbidity among people living with HIV (PLWH) and remains a leading cause of HIV-related mortality worldwide. Early preventive treatment for latent tuberculosis infection (LTBI) is essential to prevent disease progression and reduce transmission. Recently, the one-month daily combination of rifapentine and isoniazid (1HP) regimen has demonstrated high efficacy and […]
